Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 4.73% is 22% above its 5-year average of 3.88%, near the high end of its 5-year range (1.59%–4.73%).
As of the fiscal period ended Tuesday, September 30, 2025. 7.99% above its 12-month average of 4.38%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
4.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
4.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
4.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
3.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
3.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
6.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.48%
CURRENT VS TTM AVG
+7.99%
CURRENT VS 3Y AVG
+9.55%
CURRENT VS 5Y AVG
+21.75%
CURRENT VS 10Y AVG
+22.97%
CURRENT VS 15Y AVG
-27.11%
CURRENT VS 20Y AVG
-44.21%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-44.55%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$60.26B
Return on Invested Capital (ROIC)
4.73%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$62.18B
Return on Invested Capital (ROIC)
13.23%
TTM Avg
15.09%
3Y Avg
14.58%
5Y Avg
13.58%
Market Cap
$54.46B
Return on Invested Capital (ROIC)
11.37%
TTM Avg
10.09%
3Y Avg
4.86%
5Y Avg
-0.22%
Market Cap
$68.46B
Return on Invested Capital (ROIC)
8.78%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
Market Cap
$71.62B
Return on Invested Capital (ROIC)
8.51%
TTM Avg
9.70%
3Y Avg
12.91%
5Y Avg
18.22%
Market Cap
$48.18B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
Market Cap
$46.67B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$44.93B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$79.64B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
7.02%
3Y Avg
7.07%
5Y Avg
6.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Becton, Dickinson and Company (BDX) | $60.26B | 4.73% | 4.38% | 4.32% | 3.88% |
| Cencora, Inc. (COR)vs › | $62.18B | 13.23% | 15.09% | 14.58% | 13.58% |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 11.37% | 10.09% | 4.86% | -0.22% |
| Boston Scientific Corporation (BSX)vs › | $68.46B | 8.78% | 7.46% | 6.12% | 5.55% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $71.62B | 8.51% | 9.70% | 12.91% | 18.22% |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 11.40% | 11.07% | 14.43% | 15.83% |
| Humana Inc. (HUM)vs › | $46.67B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 40.27% | 37.07% | 34.89% | 35.94% |
| Cigna Corporation (CI)vs › | $79.64B | 7.35% | 7.02% | 7.07% | 6.50% |
| IQVIA Holdings Inc. (IQV)vs › | $40.61B | 8.23% | 8.41% | 8.23% | 6.99% |
ROIC
4.7%
ROE
4.7%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-09-30 | 4.73% |
| 2024-09-30 | 4.03% |
| 2023-09-30 | 4.10% |
| 2022-09-30 | 4.41% |
| 2021-09-30 | 4.45% |
| 2020-09-30 | 1.59% |
| 2019-09-30 | 3.71% |
| 2018-09-30 | 0.81% |
| 2017-09-30 | 4.40% |
| 2016-09-30 | 5.86% |
| 2015-09-30 | 4.22% |
| 2014-09-30 | 12.00% |
| 2013-09-30 | 9.78% |
| 2012-09-30 | 11.99% |
| 2011-09-30 | 13.99% |
| 2010-09-30 | 13.76% |
| 2009-09-30 | 14.82% |
| 2008-09-30 | 16.64% |
| 2007-09-30 | 14.12% |
| 2006-09-30 | 14.56% |
| 2005-09-30 | 14.08% |
| 2004-09-30 | 12.82% |
| 2003-09-30 | 13.04% |
| 2002-09-30 | 12.20% |
| 2001-09-30 | 12.30% |
| 2000-09-30 | 11.41% |
| 1999-09-30 | 10.31% |
| 1998-09-30 | 10.97% |
| 1997-09-30 | 12.62% |
| 1996-09-30 | 13.21% |
